PaxMedica Inc. Common Sto... (PXMD)

AI Score

Unlock

0.00

-0.00 (-100.00%)

At close: Mar 18, 2025, 2:54 PM

PaxMedica Common Stock Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q2 2019	Q1 2019
Period Ending	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Jun 30, 2019	Mar 31, 2019
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-3M	-3.69M	-4.39M	-4.36M	-3.36M	-4.04M	-4.98M	-2.69M	-927.39K	-2M	-1.79M	-1.71M	-1.98M	-1.71M	-2.12M	-1.64M	-1.53M	-275.22K	-137.89K	-114.38K
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-53.54K	n/a	n/a	n/a	n/a	n/a
Pretax Income	-3M	-3.69M	-5.92M	-5.05M	-3.49M	-3.83M	-5.22M	-11.46M	19.03K	1.86M	6.23M	-3.11M	-6.13M	-7.22M	-4.38M	-1.64M	-1.53M	-275.22K	-137.89K	-114.38K
Net Income	-3M	-3.69M	-5.92M	-5.05M	-3.49M	-3.63M	-5.46M	-20.23M	965.45K	5.73M	6.23M	-3.11M	-6.13M	-7.22M	-4.38M	-1.64M	-1.53M	-275.22K	-137.89K	-114.38K
Selling & General & Admin	1.49M	3.3M	3.22M	2.43M	2.77M	3.81M	4.74M	2.37M	775.96K	933.82K	1.32M	1.28M	1.09M	1.29M	1.8M	1.3M	1.45M	79.41K	29.17K	7.75K
Research & Development	1.51M	392.81K	1.16M	1.94M	589.03K	222.49K	238.09K	327.27K	151.43K	1.07M	469.13K	437.56K	889.91K	427.95K	326.27K	340.56K	74.14K	195.81K	108.72K	106.63K
Other Expenses	n/a	-3.02K	-1.88M	-325.98K	-124.42K	243.71K	-81.56K	-8.32M	1.25M	1.63M	3.98M	-606.38K	-899.13K	-2.31M	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	3M	3.69M	4.39M	4.36M	3.36M	4.04M	4.98M	2.69M	927.39K	2M	1.79M	1.71M	1.98M	1.71M	2.12M	1.64M	1.53M	275.22K	137.89K	114.38K
Interest Expense	n/a	n/a	n/a	1.31K	3.93K	3.93K	3.93K	1.31K	n/a	n/a	n/a	n/a	n/a	2.81M	607.74K	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	3M	3.69M	4.39M	4.36M	3.36M	4.04M	4.98M	2.69M	927.39K	2M	1.79M	1.71M	1.98M	1.71M	2.12M	1.64M	1.53M	275.22K	137.89K	114.38K
Income Tax Expense	n/a	-46.3K	193.76K	1.31K	3.93K	-199K	239.18K	8.77M	-946.42K	-3.87M	-8.02M	-660.38K	-954.93K	2.81M	-108.67K	-52.75K	-51.12K	-47.3K	-40.96K	-40.37K
Shares Outstanding (Basic)	7.66M	7.42M	7.4M	971.74K	860.72K	743.39K	707.98K	539.86K	10.02M	10.02M	10.02M	10.02M	10.02M	10.02M	10.02M	7.33M	7.33M	10.02M	10.02M	10.02M
Shares Outstanding (Diluted)	7.66M	7.42M	7.4M	971.74K	860.72K	743.39K	707.98K	539.86K	10.02M	10.02M	10.02M	10.02M	10.02M	10.02M	10.02M	7.33M	7.33M	10.02M	10.02M	10.02M
EPS (Basic)	-0.39	-0.5	-0.8	-5.2	-4.05	-4.89	-7.71	-37.47	0.10	0.57	0.85	-0.31	-0.61	-0.72	-0.44	-0.22	-0.21	-0.03	-0.01	-0.01
EPS (Diluted)	-0.39	-0.5	-0.8	-5.2	-4.05	-4.89	-7.71	-37.47	0.10	0.57	0.85	-0.31	-0.61	-0.72	-0.44	-0.22	-0.21	-0.03	-0.01	-0.01
EBITDA	-3M	-3.69M	-4.39M	-4.36M	-3.48M	-4.04M	-4.98M	-2.69M	19.03K	-370.3K	6.23M	-2.32M	-2.88M	-4.02M	-2.18M	-1.64M	-1.53M	-275.22K	-137.89K	-114.38K
EBIT	-3M	-3.69M	-5.92M	-5.05M	-3.48M	-3.83M	-5.22M	-11.46M	19.03K	1.86M	6.23M	-3.11M	-6.13M	-4.41M	-3.77M	-1.64M	-1.53M	-275.22K	-137.89K	-114.38K
Depreciation & Amortization	729.00	43.28K	43.81K	-325.98K	-124.42K	243.71K	-81.56K	-8.41M	949.58K	1.63M	8.02M	-606.38K	-899.13K	-2.31M	-53.54K	52.75K	51.12K	47.3K	40.96K	40.37K